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In order to outline the clinical and EEG characteristics of recurrent absence status epilepticus (ASE), eight cases with more
than two attacks of ASE were studied. Their current ages were between 13 and 84 years, and five of the patients were women.
There was a history of epilepsy in five of the patients before the first ASE episode. A varying degree of confusion was the
main clinical symptom with associated mild motor signs like perioral, eyelid and generalised myoclonus, seen in one, two and
four patients respectively. Two of the patients had juvenile myoclonic epilepsy. One patient had an atypical form of childhood
absence epilepsy characterised by recurrent ASE attacks on awakening. There were two patients with phantom absences and late
onset generalised convulsions, one patient with perioral myoclonia and absences, and finally two patients with eyelid myoclonia
with absences, which are proposed syndromes. On the EEGs that revealed the diagnosis of ASE, there was a marked variability
of the generalised multispike and wave discharges. The EEG findings appeared to be syndrome-related with some exceptions.
IV Clonazepam lead to a dramatic improvement. Our study shows that the majority of recurrent ASE cases do not fit into the
International syndrome classification.
c© 2002 Published by Elsevier Science Ltd on behalf of BEA Trading Ltd.
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INTRODUCTION
Nonconvulsive status epilepticus (NCSE) is charac-
terised by a slowness of behaviour and confusion
accompanied by continuous electroencephalographic
seizure activity1, 2. Yet, it is not known whether
NCSE causes any brain damage3–6. Absence status
epilepticus (ASE), the generalised form of NCSE
is usually known as an epileptic state with good
prognosis, but there are only a few studies about its
recurrence and syndrome diagnosis7–10. EEG is an
indispensable diagnostic tool for the diagnosis of ASE
in dealing with variations of abnormalities.
Although cases with ASE as a single recurrent
seizure type have occasionally been reported, there
are no systematic studies about the recurrent ASE
cases8. One recent study has attracted attention on this
issue7. Although it has been reported that ASE may be
seen in idiopathic generalised epilepsies (IGE), there
is limited knowledge about which epileptic syndromes
may be closely related with this state7, 8, 10.
In this study, our aim is to outline the clinical and
EEG characteristics of epileptic patients with more
than two clinically and electroencephalographically
proven ASE attacks, and to classify these cases
according to the known and ‘proposed’ epileptic
syndromes.
PATIENTS AND METHODS
Within a period of 15 years, 29 NCSE cases
were admitted to our department. The patients with
lateralising clinical or laboratory signs were excluded
from this study. There were 16 ASE cases showing
alteration in cognition and behaviour associated
with clearly symmetric, bilateral epileptic activity
on EEG during this state, and improvement with
antiepileptic drug therapy. At the time of the EEG
showing ASE, blood biochemistry parameters were
normal in all of the patients and there was no
history of intoxication or drug withdrawal in any of
the cases. Out of these 16 patients, eight patients
who had more than two clear-cut clinically and
1059–1311/02/$22.00/0 c© 2002 Published by Elsevier Science Ltd on behalf of BEA Trading Ltd.
Clinical and EEG characteristics of ASE 311
electroencephalographically proven ASE attacks were
included in this study. All of these eight patients had
a follow-up of at least two years. The clinical and
laboratory features of these eight cases were reviewed
in detail.
The EEGs were read and interpreted by two expe-
rienced electroencephalographers (AG, BB) in joint
sessions. EEG recordings were performed with scalp
electrodes placed according to the International 10–
20 system with both bipolar and referential montages.
Standard activating procedures were performed in all
patients. The ictal as well as interictal EEGs and
video-EEGs of these patients were evaluated regarding
the morphology, continuity, regularity and frequency
and associated clinical findings. The background
activity, effects of hyperventilation, intermittent photic
stimulation procedures and the effects of eye opening
and eye closure were all noted as well as the
responsiveness to IV Clonazepam, during the ASE
episode. All but one had neuro-imaging studies.
Ring chromosome 20 investigations disclosed normal
results in four patients. Detailed neuropsychological
evaluation could be done in four of them.
The patients were classified according to the
epileptic syndromes suggested by ILAE in 198911.
RESULTS
The clinical findings are outlined in detail in Table 1.
The current ages were between 13 and 84 years and
five of the eight patients were women. The mean age
at the first ASE episode was 16.5 ± 9.68 years. Five
patients were known as epileptics before the diagnosis
of ASE, while three had their first epileptic attack
as an ASE. The mean age at the first seizure was
11.69± 7.27 years.
A varying degree of confusion was the main
clinical symptom with associated mild motor signs
like perioral, eyelid and generalised myoclonus seen
in one, two and four cases, respectively.
The descriptions of the ASE episodes by the patients
and their relatives were as follows:
Case 1: Disoriented in place, walks, cannot go
home, confused, purposeless movements, prominent
blinking, sometimes head movements, can speak,
visual illusion (she says that she sees the curtains
as very small) complains of headache (misdiagnosis:
migraine equivalent!!), does not eat anything.
Case 2: Disoriented in place and time, walks in a
dazed condition, cannot go to her classroom, could
not communicate properly, cannot remember, random
jerking, looks upwards.
Case 3: Dizziness, repetitive jerking, sometimes can-
not eat and dress himself, interruptions in speaking,
cannot go to work, describes the unusual feeling like
electricity in the brain, sleepiness.
Case 4: Slurred speech, blinking, confusion, sleepi-
ness, slowness in movements, cannot write.
Case 5: Describes the episodes as ‘ending of
her intelligence’, forgetfulness, dullness, sleepiness,
elevated appetite, increased movements, awareness of
her attack, (came to hospital on her own).
Case 6: Confusion, marked perioral rhythmic
movements, forgetfulness, urinary incontinence, (her
mother says: ‘he would not understand even if you
hurt him’), swallowing difficult because of perioral
movements.
Case 7: Hears but unable to answer questions
appropriately, slowness of judgement and planned
movements, feels like a ‘sleepwalker’, continuous eye
and lid movements in upward direction, unable to
close or open her eyes.
Case 8: Awakening difficult lasting 3–5 h 1–2 times
weekly, urinary and faecal incontinence during these
episodes, slowness in behaviour, blinking, myoclonia
in the face and arms.
All patients were neurologically normal except
two who had borderline intelligence and neuro-
imaging studies disclosed normal results except mild
ventricular enlargement in case 6 and a colloidal
cyst in case 1 which were interpreted as coincidental
findings. Ictal single photon emission computed
tomography (SPECT) and hexa-methyl-propylene-
amine-oxim (HMPAO) of case 8 demonstrated gen-
eralised hyperperfusion when compared with the
interictal SPECT of the same patient.
ASE recurred 3–6 times in three patients, whereas in
the remaining five patients the recurrences were more
frequent (more than 20 to 100). The duration of ASE
varied from 20 min to 5 days as seen in Table 1. Non-
specific infections were found to be the most common
precipitating events, mentioned in six of the patients.
A temporal relationship with generalised convulsions
was demonstrated in five patients in some of the ASE
attacks. We observed prominent diagnostic delays and
misdiagnoses in six of the patients. In one of these
patients (case 3), the ASE could be diagnosed with
the video-EEG examination of the patient during this
state. Although he had complained of these episodes,
we had interpreted those as a depressive disorder and
as side effects of the treatment. EEG and video-EEG
findings are shown in Table 2.
EEG findings during ASE attacks
On the EEGs that revealed the diagnosis of ASE, there
were generalised multispike-wave discharges in all of
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Table 1: Clinical features of the recurrent ASE cases.
No. 1 2 3 4 5 6 7 8
Sex F F M F F M F M
Current age 20 25 27 28 84 17 34 13
Age at first
seizure
7 17 17 18 20 1.5 10 3
Other
seizure
types (age
at onset in
parenthe-
ses)
*abs (8) myo (23);
GTCS (17)
myo (17)
GTCS (17)
following
myo.
Rare GTCS
(18) ph. abs
(?)
Rare GTCS,
(20) ph. abs
(?)
#abs (1.5)
GTCS (16)
*abs (10) abs (6; after
treatment of
ASE)
Follow-up
(years)
12 2 9 9.5 12 2 6 7
Neurological
examination
N N N (Borderline
IQ) N
N (Borderline
IQ) N
N N
Neuroimaging
(CT/MRI)
MRI:
colloid cyst
CT:N MRI:N MRI:N Nd Moderate
ventricular
enlargement
CT: N MRI: N
History N N N Febrile
convulsion,
Bell’s palsy
Hypertension,
left heart
failure
N N Difficult
delivery
Family
history
N N Epilepsy in
aunt; Neuro-
Behc¸et
disease in
the brother
N N N Childhood
absence
epilepsy in
her nephew
Epilepsy in
the mother
Age at first
ASE
8 17 23 18 29 7 (?) 27 3
Number of
ASE attacks
6 (none
after
treatment)
3 >20 >20 >50 >100
(1–2/week)
3 >100
(1–2/week)
Duration of
ASE
(min–max)
20 min–4 h 1–4.5 h 3 h–3 days 30 min–
5 days
1–2 days 30 min–
6.5 h.
6–24 h 3–5 h
Precipitating
factors of
ASE
Infection Infection Sleep
deprivation
Menses,
drug
discontinua-
tion,
infection
None Infection Infection,
allergy
treatment
None
Temporal
relation
with GTCS
No GTCS +
(terminate
in GTCS)
+ +
(terminate
in GTCS)
+/− + No GTCS No GTCS
Treatment CLZ 3 mg
+ ETS
500 mg
Now 0.5 mg
CLZ only
VPA
1000 mg
3000 mg
VPA,
180 mg PB,
4 mg CLZ,
LTG 50 mg
750 mg
VPA
3 mg CLZ
+500 mg
VPA (She
did not use
regularly)
400 mg
CBZ
worsened;
1000 mg
VPA now
500 mg
ETS; then
500 mg
VPA
ETS 500–
750 mg
Now: no
treatment
Outcome Seizure-free
for past 2.5
years
No ASE or
GTCS with
treatment;
rare myo.
Poor
outcome,
frequent
seizures
With AED
treatment
no ASE, ph.
abs only
Without
treatment
frequent
ASE
With AED
treatment
no ASE,
mild abs.
With AED
treatment
no ASE
mild abs
Seizure free
for past 3
years
Misdiagnosis
or
diagnostic
delay
Diagnosed
as migraine
equivalent!
Diagnosis
delayed 5
years
Diagnosis
delayed 1
year
None Diagnosis
delayed 40
years
Diagnosed
as partial
epilepsy
Not
recognized
in the
emergency
unit
His family
did not
recognize
the ASE
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Table 1: Continued.
No. 1 2 3 4 5 6 7 8
Sex F F M F F M F M
Occupation Student (not
very
successful
in the
school)
Student,
married
Civil
servant
Worker Retired
teacher, had
3 children
Worker (He
could not
attain to
high school)
Housewife Student
Psychiatric
problems
None None Problems in
work,
depression
Depression
and
personality
disorder
None None None Personality
disorder
(problems
in the
school)
Ring 20 Nd (−) (−) (−) Nd Nd Nd (−)
Neuro-
psychological
testing (in
the
interictal
period)
Very mild
attention
deficit,
frontal signs
and visuo-
spatial
deficit
Nd Mild
attention
deficit,
moderate
frontal signs
Moderate
attention
deficit, mild
memory
defects in
recall
Nd Nd. Nd Mild
attention
deficit, mild
frontal signs
and visuo-
spatial
deficit
∗abs: Absences with eyelid myoclonus; #abs: Absences with perioral myoclonus; ph. abs: Phantom absence seizures; Nd: not done; N: normal;
myo: myoclonus; ASE: absence status epilepticus; AED: antiepileptic drugs; GTCS: generalised tonic–clonic seizures. (CLZ: clonazepam;
ETS: ethosuximide; VPA: valproate; PB: phenobarbitone; LTG: lamotrigine; CBZ: carbamazepine.)
the patients (Figs 1 and 2). These discharges were
continuous in three patients, whereas in the others
there were normal intervals lasting 1–6 s. In five
patients epileptic abnormalities were irregular, in the
others almost rhythmic delta waves and polyspikes
were seen. The frequency of the spike and wave
discharges ranged from 1.5 to 3.5 Hz, in two patients it
slowed down to 1.5 Hz in some parts of the recording.
The number of spikes per slow wave was greater than
one in all of the EEGs with recurrent ASE. In all of
the ASE cases IV Clonazepam induced a dramatic
improvement of clinical and/or EEG findings (Fig. 1).
Video-EEG during ASE disclosed a confusional
state and difficulty in responding and counting in three
patients. In one of the patients, bilateral myoclonic
jerks associated with rapid spike bursts on the EEG
were observed and frequent errors were noticed in
counting (Fig. 1).
Other EEG findings
The background activity was normal in the interictal
period, in all of the patients except one (case 3). In
this latter case, mild slowing was attributed to high
antiepileptic drug levels in two subsequent recordings.
Hyperventilation procedure caused an increase in
the epileptiform activity in three of the patients
and photic stimulation disclosed prominent increases
in the discharges in two cases with prominent
eyelid myoclonia. Typical generalised spike and
wave discharges following eye closure as well as
photoparoxysmal responses were observed in the
interictal EEGs of the cases 1 and 7 with eyelid
myoclonia with absences.
Video-EEG examinations could be done in five
patients in the interictal state. In two of those
investigations, (cases 3 and 8) no seizures were
observed; however, rare generalised spike and wave
discharges were noted. In video-EEG studies of our
previously published case 6, three absence seizures
were recorded with marked perioral myoclonic move-
ments almost synchronous with the spike component
of the spike-wave discharges12. Absence seizures
with eyelid myoclonia appearing on eye closure were
observed in case 7. In case 5, phantom absences were
demonstrable on video-EEG.
Syndrome diagnosis and correlation with the
EEG features
With regard to the described clinical and EEG
features of the patients, we attempted to classify them
according to the known epileptic syndromes11.
Two of them had the syndrome of juvenile
myoclonic epilepsy (JME) (cases 2 and 3). The
EEGs during ASE of these two patients had marked
similarities. We observed rapid generalised spike
(6 Hz) bursts associated with generalised myoclonus,
followed by less prominent delta waves and frequent
interruptions lasting 1–4 s during the ASE (Fig. 1).
The main characteristics of the EEG pattern did not
change through the recorded periods. Although these
two JME patients showed a highly similar pattern of
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(a)
(b)
Fig. 1: (a) Video-EEG examples of case 3 with JME during ASE. Note that the discharges are discontinuous and non-rhythmic
with prominent rapid (5–6 Hz) spikes associated with myoclonic jerks of the upper extremities and moderate confusion. The spike
bursts are usually followed by delta waves and there are interruptions lasting a few seconds between the seizure discharges;
(b) demonstrates the dramatic effect of IV clonazepam. The patient feels improvement, he falls asleep and the seizure discharges
disappear completely.
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(a)
(b)
Fig. 2: (a),(b): EEG tracings of case 4 with phantom absences and rare generalised convulsions showing the identical EEG
pattern during 2 ASE attacks in the years 1989 (a) and 1997 (b). Note that the discharge is continuous with poly-spikes and
prominent slow waves.
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Table 2: EEG findings of the recurrent ASE cases.
1 2 3 4 5 6 7 8
During ASE Figure 1(a), (b) Figure 2(a), (b)
Morphology Multi-SW Multi-SW Multi-SW Multi-SW Multi-SW Multi-SW Multi-SW Multi-SW
Regularity Yes No No Yes No Yes No No
Continuity
(interrup-
tions)
Yes No (1–3 s) No (2–4 s) Yes No (2–4 s) No (1–2 s) No (1–6 s) Yes
IV (CLZ) Effective Effective Effective Effective Effective Effective Effective Effective
Video
findings
Not done Not done Difficulty in
counting and
frequent myo.
Not done Mild
confusion,
difficulty in
counting
Not done Not done Marked
confusion
Observation
of technician
or physician
Eyelid
myoclonus
Generalised
myoclonus
Generalised
myoclonus
Random
jerks and
rare eye
blinking
Rare eyelid
blinking
Perioral
myoclonus
Eyelid
myoclonus
Facial and
generalised
myoclonus
Interictal
period
Background
activity
Normal Normal Mild slowing
due to drugs
Normal Normal Normal Normal Normal
Routine
EEG
SW, Right
temporal S
N (Under VPA
therapy)
Multi-SW Multi-SW N/rare
Multi-SW
Rare SW
(R > L)
Frequent SW Rare irregular
SW
Video-EEG
findings
Not done Not done Multi-SW Not done Phantom
absence
seizures
Perioral
myoclonia
with absence
seizures
Eyelid
myoclonia
with absence
seizures
Normal sleep
and
wakefulness
with rare SW
on awakening
Eye closure + (SW) N N N N N + (SW) −
Hyperventi-
lation
+ N +/− + − Mild + − −
Photic stim. + (15 Hz) N N N − − + (on eye
closure)
−
SW: spike and wave; CLZ: clonazepam; +: epileptic discharges started or prominently enhanced. R: right; L: left; VPA: valproate.
ASE on the EEG, their clinical courses were different
regarding the response to AED therapy. Case 2 had
only three attacks of ASE before appropriate treatment
was started whereas the other patient (case 3) had
frequent attacks despite treatment. On the other hand,
in that latter case, ASE attack responded markedly
to IV Clonazepam, like all of the other cases
(Fig. 1(b)).
The youngest patient (case 8) had childhood absence
epilepsy (CAE) with very frequent ASE attacks
on awakening during childhood. However, the EEG
pattern during the late phases of ASE of this case
seemed to be somewhat atypical for this syndrome,
regarding the marked irregularity. This case is still in
remission for the past three years, but his long-term
video-EEG demonstrates rare generalised spike and
wave discharges in the awakening hours.
The remaining five patients with recurrent ASE
could not be classified; they had no definite place
in the existing classification of the IGE phenomena.
Among these five cases, two cases had eyelid
myoclonia with absence seizures (EMA) (cases 1
and 7). They both had only three to six ASE attacks
before treatment, while they did not have any attacks
after treatment. Their EEGs during ASE showed
discontinuous repetitive discharges of multispikes and
slow waves associated with eyelid myoclonia and
impairment of consciousness. Both of these patients
also had eyelid myoclonia with absence seizures
of short duration appearing on eye closure and
photoparoxysmal responses.
Two other patients with more numerous ASE
recurrences had phantom absences (PA) and late onset
generalised convulsions (cases 4 and 5). Their EEG
patterns were not similar regarding continuity but they
shared a similar multi-spike pattern. The patterns of
the ASE EEGs did not change during the course over
years (Fig. 2(a), (b)) in these two cases.
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The remaining patient had perioral myoclonia with
absences (PMA) (case 6). His EEG during ASE
disclosed a highly regular pattern of 4 Hz spike-waves
with 2–3 spikes per wave. There were rare and very
short normal intervals12.
Response to treatment and outcome
Since the effects of different antiepileptic drugs
cannot be properly evaluated in such a small group,
evaluation of the treatment effects is beyond the scope
of this study. The follow-up period ranged from 2
to 12 years. Two patients were seizure-free after
treatment with ethosuximide and clonazepam. Five
patients were treated with low to moderate doses
of valproate. Clonazepam was also effective in two
patients. Carbamazepine was reported to worsen the
ASE attacks in case 6. Ethosuximide was also used in
three cases with absence seizures. The oldest patient
(case 5) with a diagnostic delay of 40 years refused
to take the medicine regularly. She used small doses
of clonazepam, when her attacks recurred. Case 3
continues to have generalised tonic–clonic seizures
and ASE attacks despite treatment with various
combinations of appropriate antiepileptic drugs.
DISCUSSION
Nonconvulsive status epilepticus (NCSE) accounts
for approximately one-quarter of all cases of status
epilepticus13. The actual proportion may be higher
because patients with NCSE often go unrecognised,
or are mistaken to have behavioural or psychiatric
disorders. The heterogeneous clinical presentation of
NCSE indicates that EEG and a therapeutic trial
of AEDs afford the best diagnostic measures in
acute confusional states2. This disorder may be
divided into generalised (absence) or partial (complex
partial) forms. ASE is considered more frequent
and is characterised by a continuous neurocognitive
alteration13. ASE is reported to occur in 3% of
all patients who have absence seizures8. Tomson
et al.14 reported the annual incidence of NCSE as 1.5
in 100 000 inhabitants. In their series, which included
all NCSE cases, the median age at onset of status
was 51 years, markedly older when compared with our
group comprising only recurrent ASE cases14.
For ASE to be distinguished from the state of
focal NCSE (complex partial nonconvulsive sta-
tus epilepticus) clinical and EEG findings should
be evaluated together with extreme care and this
sometimes causes great difficulty1, 15. However, it is
important to differentiate between complex partial
status epilepticus (CPSE) and ASE since, in the case of
ASE first choice treatment should include anti-absence
drugs. Kaplan16 evaluated causes of diagnostic and
management delay and examined frequent diagnostic
features in a retrospective study of 23 patients with
NCSE. We also observed that the correct diagnosis
was significantly delayed in the majority of cases.
Brinciotti et al.17 observed an increased incidence
of convulsions among the relatives of probands with
NCSE, but no difference was noted between epileptic
children with or without NCSE. We also noticed a
remarkable family history in our small group.
Most of the cases had a history of epilepsy before
ASE, although the first epileptic attack might be
seen as an ASE in some of the relevant reports2, 10.
Approximately one-third of the NCSE patients had
status as their first epileptic manifestation in the study
of Tomson et al.14. Similarly, in our series, more than
half of the cases had a history of epilepsy before ASE.
EEG is the best diagnostic tool for ASE. Except for
rarely reported special findings such as generalised
fast activity18, the diagnosis becomes certain with
the occurrence of continuous or frequently recurring
generalised spike and wave discharges8, 19. IV Clon-
azepam led to rapid resolution of ASE. Kaplan16
reported the absence of evident epileptic findings on
EEGs of some patients in a heterogeneous group of
NCSE cases. In contrast, the number of spikes per
wave was greater than one in our group of recurrent
ASE cases. Granner and Lee19 stated that the ictal
discharges tended to be relatively slow in NCSE. We
found also in some of the ASE EEGs, the frequency
of the generalised spike and wave discharges slowed
down to 1.5 Hz.
Inoue et al.20 described a distinct epileptic syn-
drome associated with ring chromosome 20, with fre-
quent seizures consisting of a prolonged confusional
state and an ictal EEG pattern of bilateral high-voltage
slow waves with occasional spikes. We investigated
the suspected cases in our group, but could not find
any case with this peculiar chromosomal abnormality.
Patients with JME can develop NCSE, which may
be overlooked because of the subtle clinical symp-
toms21. The EEG pattern of ASE is highly typical with
rapid spike bursts associated with myoclonus in our
two JME cases.
It is reported that in some cases ASE was frequently
recurring and seen as a major seizure type8, 9, 14.
Guberman et al.1 mentioned recurring attacks in
spite of antiepileptic drug treatment. Berkovic et al.9
showed that VPA prevented recurrence of ASE in
the group with unclassified IGE. Despite the limited
number of the cases, our study suggests that ASE
frequently recurs in some cases and can be the
characteristic seizure type for some epileptic patients.
Recently new epilepsy syndromes frequently seen
in ASE are being reported. Among those, epilepsy
with eyelid myoclonia and absences (EMA), which
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was seen in two of our cases, was the first one22.
Wakomoto et al.23 described another case with EMA
in whom ASE developed shortly after awakening.
It has been reported that ASE appears to be related
with the highest prevalence to the syndromes of PA
with generalised tonic–clonic seizures and PMA7. It is
possible to diagnose these syndromes with video-EEG
recordings. From this point of view, it is necessary to
examine the NCSE cases with video-EEG recordings,
and a long follow-up period is required. Our study
confirmed that the syndrome with mild (phantom)
absences and late onset generalised convulsions is
associated with recurrent ASE24. Our long-term
follow-up demonstrated that the typical EEG pattern
did not change during the course despite treatment
in this peculiar syndrome. PMA is another rare
and recently described epileptic state with distinctive
clinical features25, 26.
It has been reported that NCSE responded to treat-
ment with carbamazepine, with increased intracranial
pressure and transient abnormalities observed on
MRI27. One of our patients was markedly worsened
when treated with carbamazepine because of a wrong
diagnosis of partial epilepsy. Intravenous valproate
may provide an effective treatment alternative to
benzodiazepines in ASE without their associated
morbidity28.
There is no convincing evidence of any brain
damage related to recurrent ASE in our study. Our
study showed that recurrent ASE permitted a normal
life span for most of the patients and supported the
opinion that nonconvulsive status epilepticus is not
very harmful3, 4. Krumholz29 reported that typical
ASE does not appear to have very serious conse-
quences and may be a type of ‘inhibitory’ seizure.
It is remarkable that ASE can recur in some patients
and most of them could not be classified according
to the known epileptic syndromes. The recurrent type
of ASE may provide an opportunity for a better
understanding of epileptogenesis and the mechanism
of status epilepticus in future studies.
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